After Hours Summary: NSA +4% on S&P SmallCap 600 addition news, WDC -2% following guidance (STX also lower)After Hours Gainers:
Companies trading higher in after hours in reaction to news: TOPS +30.9% (higher after announcing financial information after reverse stock split on June 23), NSA +4% (will replace Blackbaud in the S&P SmallCap 600), RAD +3.7% (continued strength on potential WBA / RAD FTC approval), THC +3.4% (following CBO score on Better Care Reconciliation Act of 2017 - Senate healthcare bill), KMPH +2.9% (announces patent for KP746), AMRN +2.9% (attributed to positive analyst comments), ESPR +1.7% (says the FDA recently confirmed the regulatory pathway to approval for the once-daily, oral combination pill of bempedoic acid 180 mg and ezetimibe 10 mg), AHH +1.2% (Pres/CEO disclosed purchase of 10000 shares worth approx $134K)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: WDC -2.2%
Companies trading lower in after hours in reaction to news: FNJN -10.2% (commenced an underwritten registered public offering of common stock), RGEN -6% (Repligen commences underwritten public offering of $100 mln in shares of its common stock), RGEN -6% (light volume; commences underwritten public offering of $100 mln in shares of common stock), NEOS -4.1% (proposed offering of common stock), ARR -3.7% (commences underwritten public offering of 4.5 mln shares of common stock), BLUE -2.1% (announces topline interim data from the initial cohort of 17 patients in the ongoing Phase 2/3 Starbeam Study evaluating Lenti-D in boys under 18 years old with cerebral adrenoleukodystrophy; commences underwritten public offering of $350 mln of its common stock), STX -2.1% (following WDC guidance)
